143 related articles for article (PubMed ID: 19588471)
1. Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2(High) receptor.
Seeman P; Guan HC
Synapse; 2009 Oct; 63(10):935-9. PubMed ID: 19588471
[TBL] [Abstract][Full Text] [Related]
2. Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors.
Seeman P; Guan HC
Synapse; 2009 Aug; 63(8):705-9. PubMed ID: 19391149
[TBL] [Abstract][Full Text] [Related]
3. Dopamine partial agonist actions of the glutamate receptor agonists LY 354,740 and LY 379,268.
Seeman P; Caruso C; Lasaga M
Synapse; 2008 Feb; 62(2):154-8. PubMed ID: 18000815
[TBL] [Abstract][Full Text] [Related]
4. The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2(High) receptors.
Seeman P; Tokita K; Matsumoto M; Matsuo A; Sasamata M; Miyata K
Synapse; 2009 Oct; 63(10):930-4. PubMed ID: 19588469
[TBL] [Abstract][Full Text] [Related]
5. Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia.
Seeman P; Guan HC
Synapse; 2008 Nov; 62(11):819-28. PubMed ID: 18720422
[TBL] [Abstract][Full Text] [Related]
6. Memantine agonist action at dopamine D2High receptors.
Seeman P; Caruso C; Lasaga M
Synapse; 2008 Feb; 62(2):149-53. PubMed ID: 18000814
[TBL] [Abstract][Full Text] [Related]
7. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO.
Seeman P; Battaglia G; Corti C; Corsi M; Bruno V
Synapse; 2009 Mar; 63(3):247-51. PubMed ID: 19084908
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil.
Seeman P; Guan HC; Hirbec H
Synapse; 2009 Aug; 63(8):698-704. PubMed ID: 19391150
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking.
Salmas RE; Seeman P; Aksoydan B; Erol I; Kantarcioglu I; Stein M; Yurtsever M; Durdagi S
ACS Chem Neurosci; 2017 Jun; 8(6):1404-1415. PubMed ID: 28272861
[TBL] [Abstract][Full Text] [Related]
10. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
[TBL] [Abstract][Full Text] [Related]
12. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
Malmberg ; Mikaels ; Mohell N
J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
[TBL] [Abstract][Full Text] [Related]
13. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
14. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
Seeman P; Ko F; Willeit M; McCormick P; Ginovart N
Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
[TBL] [Abstract][Full Text] [Related]
15. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
Seeman P
Synapse; 2012 Jan; 66(1):88-93. PubMed ID: 21954082
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
18. Absence of direct effects on the dopamine D2 receptor by mGluR2/3-selective receptor agonists LY 354,740 and LY 379,268.
Zysk JR; Widzowski D; Sygowski LA; Knappenberger KS; Spear N; Elmore CS; Dorff P; Liu H; Doherty J; Chhajlani V
Synapse; 2011 Jan; 65(1):64-8. PubMed ID: 20506301
[TBL] [Abstract][Full Text] [Related]
19. In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors.
Jordan S; Chen R; Fernalld R; Johnson J; Regardie K; Kambayashi J; Tadori Y; Kitagawa H; Kikuchi T
Eur J Pharmacol; 2006 Jul; 540(1-3):53-6. PubMed ID: 16730695
[TBL] [Abstract][Full Text] [Related]
20. An agonist at glutamate and dopamine D2 receptors, LY404039.
Seeman P
Neuropharmacology; 2013 Mar; 66():87-8. PubMed ID: 22884896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
